Related Experiment Videos

Factors influencing fluoroquinolone resistance

Daniel F Sahm, Clyde Thornsberry, Mark E Jones

Emerging Infectious Diseases

|January 17, 2004

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-term trends in ceftolozane-tazobactam susceptibility among gram-negative pathogens in the United States: a nine-year SMART analysis (2016-2024).

JAC-antimicrobial resistance·2026

Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024.

Frontiers in cellular and infection microbiology·2026

Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016-2024.

Antibiotics (Basel, Switzerland)·2025

In vitro activity of gepotidacin against urinary tract infection isolates of Enterobacterales, Enterococcus faecalis, and Staphylococcus saprophyticus.

Antimicrobial agents and chemotherapy·2025

Antimicrobial Activity of Imipenem/Relebactam and Comparator Agents Against Gram-Negative Isolates Collected From Pediatric Patients: SMART 2018-2022 Global Surveillance.

Journal of the Pediatric Infectious Diseases Society·2025

Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22.

JAC-antimicrobial resistance·2024

See all related articles